BACKGROUND: HIV-positive patients receiving antiretroviral therapy (ART) who engage in HIV transmission behaviors may harbor and transmit drug-resistant HIV. However, little is known about the risk behaviors of these patients, potential partners exposed and the relationship of these to ART resistance. OBJECTIVE: To determine the relationship of HIV drug resistance and continuing HIV transmission risk behavior among HIV-positive patients in care. METHODS: A retrospective, cross-sectional study of HIV transmission risk behavior and HIV drug resistance data from 333 HIV-positive patients. RESULTS: Among a diverse population of 333 HIV-positive patients, 75 (23%) had unprotected sex during the previous 3-months, resulting in 1126 unprotected sexual events with 191 partners of whom 155 were believed by patients to be HIV-negative or of unknown status. Eighteen of the 75 (24%) had resistant HIV and 207 unprotected sexual events, exposing 18% of the HIV- or status unknown partners. There was no difference in the proportion of patients engaging in unprotected sex who had undetectable viral load (VL) (22%): VL > 400 copies/ml without resistance (20%) and VL > 400 copies/ml with resistance (26%). Resistance and risk behavior was predicted only by lower mental health scores (odds ratio, 10.3; 95% confidence interval, 1.7-18.6). CONCLUSION: A substantial minority (23%) of patients in clinical care engaged in HIV sexual transmission risk behavior. A small subset of these also had ART-resistant HIV. However, this core group (approximately 5% of all patients) accounted for a large number of high-risk HIV transmission events with resistant virus, exposing a substantial number of partners.
BACKGROUND: HIV-positive patients receiving antiretroviral therapy (ART) who engage in HIV transmission behaviors may harbor and transmit drug-resistant HIV. However, little is known about the risk behaviors of these patients, potential partners exposed and the relationship of these to ART resistance. OBJECTIVE: To determine the relationship of HIV drug resistance and continuing HIV transmission risk behavior among HIV-positive patients in care. METHODS: A retrospective, cross-sectional study of HIV transmission risk behavior and HIV drug resistance data from 333 HIV-positive patients. RESULTS: Among a diverse population of 333 HIV-positive patients, 75 (23%) had unprotected sex during the previous 3-months, resulting in 1126 unprotected sexual events with 191 partners of whom 155 were believed by patients to be HIV-negative or of unknown status. Eighteen of the 75 (24%) had resistant HIV and 207 unprotected sexual events, exposing 18% of the HIV- or status unknown partners. There was no difference in the proportion of patients engaging in unprotected sex who had undetectable viral load (VL) (22%): VL > 400 copies/ml without resistance (20%) and VL > 400 copies/ml with resistance (26%). Resistance and risk behavior was predicted only by lower mental health scores (odds ratio, 10.3; 95% confidence interval, 1.7-18.6). CONCLUSION: A substantial minority (23%) of patients in clinical care engaged in HIV sexual transmission risk behavior. A small subset of these also had ART-resistant HIV. However, this core group (approximately 5% of all patients) accounted for a large number of high-risk HIV transmission events with resistant virus, exposing a substantial number of partners.
Authors: Anders Ragnarsson; Anna Mia Ekström; Jane Carter; Festus Ilako; Abigail Lukhwaro; Gaetano Marrone; Anna Thorson Journal: J Int AIDS Soc Date: 2011-04-18 Impact factor: 5.396
Authors: Kartik K Venkatesh; A K Srikrishnan; Kenneth H Mayer; N Kumarasamy; Sudha Raminani; E Thamburaj; Lakshmi Prasad; Elizabeth W Triche; Suniti Solomon; Steven A Safren Journal: AIDS Patient Care STDS Date: 2010-11-22 Impact factor: 5.078
Authors: Matthew J Mimiaga; Katie Biello; Sari L Reisner; Heidi M Crane; Johannes Wilson; Chris Grasso; Mari M Kitahata; Wm Christopher Mathews; Kenneth H Mayer; Steven A Safren Journal: Health Psychol Date: 2015-02-02 Impact factor: 4.267
Authors: Tracey E Wilson; David Vlahov; Stephen Crystal; Judith Absalon; Susan J Klein; Robert H Remien; Robert H Remein; Bruce Agins Journal: J Urban Health Date: 2006-01 Impact factor: 3.671
Authors: Jeanette M Tetrault; Michael J Kozal; Jennifer Chiarella; Lynn E Sullivan; An T Dinh; David A Fiellin Journal: J Addict Med Date: 2013 Mar-Apr Impact factor: 3.702
Authors: Victoria L Demetriou; David A M C van de Vijver; Ioanna Kousiappa; Claudia Balotta; Bonaventura Clotet; Zehava Grossman; Louise B Jørgensen; Snjezana Z Lepej; Itzchak Levy; Claus Nielsen; Dimitrios Paraskevis; Mario Poljak; Francois Roman; Lidia Ruiz; Jean-Claude Schmidt; Anne-Mieke Vandamme; Kristel Van Laethem; Jurgen Vercauteren; Leondios G Kostrikis Journal: PLoS One Date: 2010-06-08 Impact factor: 3.240
Authors: Homero E Del Pino; Mignon R Moore; Jagadisa-Devasri Dacus; William J McCuller; Lawrence Fernandez; Alison A Moore Journal: J Gay Lesbian Soc Serv Date: 2016-01-29